Example: marketing

On Internal Audit Of Pharmaceutical Industry

Found 4 free book(s)
Technical Guide on Internal Audit of Pharmaceutical Industry

Technical Guide on Internal Audit of Pharmaceutical Industry

kb.icai.org

pharmaceutical industry, the key drivers of pharmaceutical industry, technical aspects peculiar to the industry and internal audit procedures with respect to certain processes which would help the readers in conducting internal audit of a pharmaceutical company. This Guide explains in brief the key drivers of

  Internal, Pharmaceutical, Industry, Audit, Internal audit, Pharmaceutical industry, On internal audit of pharmaceutical industry, Of pharmaceutical industry

Compliance risk assessments - Audit, Consulting, Advisory ...

Compliance risk assessments - Audit, Consulting, Advisory ...

www2.deloitte.com

A traditional internal audit risk assessment is likely ... to an industry or organization—for example, worker safety regulations for manufacturers or rules governing the behavior of sales representatives in the pharmaceutical industry. Other compliance risks transcend industries or geographies, such as conflicts of interest, harassment,

  Internal, Pharmaceutical, Industry, Audit, Internal audit, Pharmaceutical industry

Under ASC 605 - Deloitte US | Audit, Consulting, Advisory ...

Under ASC 605 - Deloitte US | Audit, Consulting, Advisory ...

www2.deloitte.com

Mar 03, 2016 · Restatements and inquiries into the revenue recognition practices in the pharmaceutical industry underscore the need for entities to (1) focus on the criteria for recognizing revenue on the sale of pharmaceutical products and (2) consider various factors in estimating returns, chargebacks, rebates, ... or when there are inadequate internal controls

  Internal, Pharmaceutical, Under, Industry, Audit, Pharmaceutical industry, Of pharmaceutical, Under asc 605

Incoming Materials Check - United States Pharmacopeia

Incoming Materials Check - United States Pharmacopeia

www.usp.org

Industry: Traditional Quality System Vulnerabilities (e.g.) 1. Lack of traceability 2. High complexity due to increased brokerage and trade activity • Many suppliers are solely distributors. To protect their enterprise, the COA is often altered to remove true identity of the manufacturer 3. Ingredient may be repackaged or relabeled multiple ...

  United, States, Pharmacopeia, Industry, United states pharmacopeia

Similar queries